205 related articles for article (PubMed ID: 3457610)
1. Estrone sulfate: a potential source of estradiol in human breast cancer tissues.
Santner SJ; Leszczynski D; Wright C; Manni A; Feil PD; Santen RJ
Breast Cancer Res Treat; 1986; 7(1):35-44. PubMed ID: 3457610
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
3. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.
Santner SJ; Ohlsson-Wilhelm B; Santen RJ
Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138
[TBL] [Abstract][Full Text] [Related]
4. Estrone sulfate stimulates growth of nitrosomethylurea-induced breast carcinoma in vivo in the rat.
Santner SJ; Levin MC; Santen RJ
Int J Cancer; 1990 Jul; 46(1):73-8. PubMed ID: 2365501
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
Pasqualini JR; Gelly C; Nguyen BL
Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
[TBL] [Abstract][Full Text] [Related]
7. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens.
Santner SJ; Santen RJ
J Steroid Biochem Mol Biol; 1993 May; 45(5):383-90. PubMed ID: 8388710
[TBL] [Abstract][Full Text] [Related]
9. 17 Beta-hydroxysteroid dehydrogenase in human breast cancer: analysis of kinetic and clinical parameters.
Leszczynski D; Santner SJ; Feil PD; Santen RJ
Steroids; 1988; 51(3-4):299-316. PubMed ID: 2851200
[TBL] [Abstract][Full Text] [Related]
10. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
11. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
12. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
13. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
14. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 17 beta-hydroxysteroid dehydrogenase in a newly-established human breast carcinoma cell line.
Mehta RR; Das Gupta TK
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):623-9. PubMed ID: 8240985
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.
Pollow K; Boquoi E; Baumann J; Schmidt-Gollwitzer M; Pollow B
Mol Cell Endocrinol; 1977 Feb; 6(4-5):333-48. PubMed ID: 14041
[TBL] [Abstract][Full Text] [Related]
17. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
18. Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase.
Masamura S; Santner SJ; Santen RJ
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):425-9. PubMed ID: 8903427
[TBL] [Abstract][Full Text] [Related]
19. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
20. Estrone sulfate analogs as estrone sulfatase inhibitors.
Li PK; Pillai R; Dibbelt L
Steroids; 1995 Mar; 60(3):299-306. PubMed ID: 7792836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
